São Paulo: 37-year-old male, origin DRC. Fever on arrival. Ebola initial test: negative. Meningitis test: positive. Patient intubated — condition serious. Ebola investigation: OPEN.
Rio de Janeiro: Male, origin Uganda. Symptoms: cough, chills, diarrhea. Malaria test: positive. Ebola investigation: OPEN.
São Paulo state government statement: "The technical assessment indicates that the risk of Ebola being introduced into Brazil and South America remains very low." This article will be updated as official laboratory results are released.
On May 31, 2026, Brazil became the first country in South America to simultaneously investigate two suspected Ebola cases — in its two largest cities. Neither has been confirmed. Both are still being investigated. This article explains why that is not a contradiction — and why the response you are seeing is the system working exactly as designed.
The Two Cases — Facts Only
Why Other Diagnoses Don't Close an Ebola Investigation
This is the question generating the most confusion in media coverage today — and it deserves a precise clinical answer. When a patient tests positive for meningitis or malaria, why doesn't that immediately close the Ebola investigation?
The answer has two parts. First: co-infection is possible. A patient can have malaria and Ebola simultaneously. A patient can have bacterial meningitis and Ebola simultaneously. One diagnosis does not exclude the other. In resource-limited settings in Central Africa, co-infections are common — and they frequently complicate and worsen clinical outcomes. The presence of another pathogen cannot be used as evidence of the absence of Ebola.
Second: the initial Ebola PCR test has timing limitations. In the earliest days of Ebola infection — particularly before day 3 of symptom onset — viral load may be below the detection threshold of even a sensitive RT-PCR test. A negative result on day 1 or day 2 is not the same as a negative result on day 5 or day 6. This is why international protocols require serial testing over time, not a single negative result, before a case can be de-escalated.
Not Everything Is Ebola — The Differential Diagnosis
The most important epidemiological fact in evaluating a febrile traveler from the DRC or Uganda is one that most headlines omit: Ebola is not the most likely diagnosis. It is not even close to the most likely diagnosis. The DRC and Uganda are countries where dozens of serious febrile illnesses circulate simultaneously — and where travelers are far more likely to present with malaria, typhoid, or dengue than with Ebola, even during an active outbreak.
| Diagnosis | Probability in DRC/Uganda traveler with fever | Shares Ebola symptoms? |
|---|---|---|
| Malaria (P. falciparum) | Very high — most common cause | Yes — fever, chills, headache |
| Typhoid fever | High | Yes — fever, abdominal symptoms |
| Dengue | Moderate | Yes — fever, myalgia, rash |
| Bacterial meningitis | Moderate | Yes — fever, headache, altered consciousness |
| Leptospirosis | Moderate | Yes — fever, myalgia, jaundice |
| Viral hemorrhagic fevers (inc. Ebola) | Low — but cannot be excluded during outbreak | Definitionally |
This is not a reason for complacency. It is the reason the protocol exists. Because Ebola looks like many things before it reveals itself — and because missing it has catastrophic consequences — every case that meets the epidemiological criteria must be fully investigated, regardless of what other diagnoses are found along the way. The two patients in São Paulo and Rio are correctly classified as suspected cases. The finding of meningitis and malaria does not reduce the clinical importance of completing the investigation.
How Did These Patients Reach Brazil? — Entry Surveillance and Its Real Limits
Both patients arrived in Brazil by air — from the DRC and Uganda respectively. Since the DRC declared its current Ebola outbreak on May 15, 2026, Brazilian airports serving international routes from affected countries have implemented enhanced entry health screening: symptom checks, travel history questionnaires, and thermal scanning where available.
But — as the 2014 Thomas Eric Duncan case demonstrated definitively — airport entry screening cannot catch what it cannot see. A traveler who is in the incubation period of Ebola is not symptomatic, does not have a fever, and passes every screening checkpoint without triggering any alert. Ebola's incubation period ranges from 2 to 21 days. A traveler can board a flight from Kinshasa looking and feeling completely well, and develop symptoms only after arrival.
This is why hospital-level clinical awareness is the true last line of surveillance defense. Both patients in Brazil were identified not because they were intercepted at the border, but because they developed symptoms, sought medical care, and disclosed their travel history. That is how outbreak detection is supposed to work — and it is a testament to the clinical vigilance of the Brazilian infectious disease system that both cases were flagged immediately and correctly.
What the Protocol Actually Looks Like
The phrase "under investigation" appears in every headline about these cases. Here is what it means in practice — step by step.
The Outbreak Context — Why Brazil Is Right to Take This Seriously
The DRC declared its current Ebola outbreak on May 15, 2026 — just 16 days ago. By May 31, the WHO reports more than 906 suspected cases and 223 deaths among suspected cases, with 134 confirmed cases and 18 confirmed deaths. The outbreak has already crossed into Uganda, which has reported 9 confirmed cases and 1 death.
The strain circulating is Bundibugyo virus — a less common Ebola species with no approved vaccine or targeted treatment. The WHO Director-General visited treatment centers on the ground in the DRC on May 31, reporting that five patients have recovered — clinically significant evidence that survival is possible without specific antivirals, but also a sobering reminder of the mortality burden this strain carries.
MSF has publicly stated that the virus is spreading faster than the response, calling for immediate expansion of testing, faster deployment of health workers, and sustained supply access. The outbreak is not contained. In that context, any connection between the epicenter and the rest of the world — through air travel, commercial routes, or family movement — represents a real pathway for introduction into new territories. Brazil, as South America's largest country with major air connections to Africa, is appropriately alert.
"The cases in São Paulo and Rio are not evidence that Ebola has reached Brazil. They are evidence that Brazil's surveillance system is detecting what it is supposed to detect."
No Infection Consulting & Education · May 31, 2026What Would Actually Change the Alert Level
For the record — because this is the question that matters — here is what would constitute a genuine escalation of this situation, as opposed to what is happening now:
A confirmed positive Ebola RT-PCR test in either patient — that is the threshold. Not a suspected case. Not a positive for another pathogen. A confirmed, laboratory-verified Ebola diagnosis. At that point, the protocol shifts from investigation to response: case management under full BSL-4 equivalent precautions, notification of all identified contacts, activation of national and international response mechanisms, and formal WHO declaration if transmission is confirmed.
As of the time of this publication, that threshold has not been crossed. Both cases remain at the investigation stage. The appropriate response from the public and from healthcare systems in the region is vigilance — not panic. Know the symptoms. Know who is at risk. Know the protocol. And trust that the system is currently doing its job.
Stay ahead of outbreak developments with physician-led IPC intelligence and online certification courses.
View All Courses →